0.68 - 0.75
0.33 - 0.86
18.34M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.74%
Revenue growth under 50% of 3606.HK's 1.62%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
44.00%
Positive gross profit growth while 3606.HK is negative. John Neff would see a clear operational edge over the competitor.
175.08%
Positive EBIT growth while 3606.HK is negative. John Neff might see a substantial edge in operational management.
175.08%
Positive operating income growth while 3606.HK is negative. John Neff might view this as a competitive edge in operations.
228.07%
Positive net income growth while 3606.HK is negative. John Neff might see a big relative performance advantage.
228.28%
Positive EPS growth while 3606.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
228.28%
Positive diluted EPS growth while 3606.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.00%
Slight or no buybacks while 3606.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.00%
Reduced diluted shares while 3606.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-99.98%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-63.53%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-57.45%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-51.09%
Negative 10Y revenue/share CAGR while 3606.HK stands at 117.77%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
8.87%
5Y revenue/share CAGR under 50% of 3606.HK's 34.79%. Michael Burry would suspect a significant competitive gap or product weakness.
-51.44%
Negative 3Y CAGR while 3606.HK stands at 33.30%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-2256.08%
Negative 10Y OCF/share CAGR while 3606.HK stands at 35.57%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-2477.32%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
5.55%
Positive 3Y OCF/share CAGR while 3606.HK is negative. John Neff might see a big short-term edge in operational efficiency.
-9.39%
Negative 10Y net income/share CAGR while 3606.HK is at 78.70%. Joel Greenblatt sees a major red flag in long-term profit erosion.
37.21%
Positive 5Y CAGR while 3606.HK is negative. John Neff might view this as a strong mid-term relative advantage.
153.00%
3Y net income/share CAGR above 1.5x 3606.HK's 47.46%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
65.53%
Below 50% of 3606.HK's 219.54%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
71.18%
5Y equity/share CAGR above 1.5x 3606.HK's 42.81%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-9.27%
Negative 3Y equity/share growth while 3606.HK is at 29.22%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-99.92%
Cut dividends over 10 years while 3606.HK stands at 157.69%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-99.99%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
9.71%
Our AR growth while 3606.HK is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-1.97%
Inventory is declining while 3606.HK stands at 0.78%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.97%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
6.25%
BV/share growth above 1.5x 3606.HK's 2.73%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-16.11%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-32.73%
Our R&D shrinks while 3606.HK invests at 7.36%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-4.50%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.